Braveheart Bio, Inc. · NASDAQ:BRVE

Orbimed Advisors LLC reported a 17.20% stake in Braveheart Bio, Inc. (Schedule 13D)

Event Aug 7, 2026 · Filed Aug 18, 2026

Orbimed Advisors LLC reported a 17.20% stake in Braveheart Bio, Inc., 12,175,159 shares, with active intent on Aug 7, 2026. Filed Aug 18, 2026 (Schedule 13D).

Stake
17.20%
Shares
12,175,159
Intent
Active
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC17.20%12,175,159
OrbiMed Capital GP IX LLC16.90%11,901,826
OrbiMed Genesis GP LLC0.40%273,333

Source

View original at SEC

Related